Literature DB >> 1543222

Excimer laser intrastromal keratomileusis.

L Buratto1, M Ferrari, P Rama.   

Abstract

We studied 30 eyes in 22 patients with severe myopia who underwent myopic keratomileusis combined with excimer laser refractive correction. The goals of the study were to evaluate the efficacy of the procedure in decreasing myopia, to assess the response of the cornea to intrastromal photoablation, and to examine the relationship between the number of laser pulses and the refractive correction achieved. The patients were observed for six months. The technique demonstrated a marked refractive reduction (from 171.875 +/- 3.32 diopters to -2.125 +/- 1.40 diopters) and an excellent corneal response to photoablation. An average decrease of 7.63 diopters was observed in keratometry readings. No marked change in the degree of astigmatism was observed after the procedure. Intrastromal haze was observed biomicroscopically in three of 30 eyes (10%). Postoperative best-corrected visual acuity remained at the preoperative level in 22 eyes (74%), improved in five eyes (16%), and declined in three eyes (10%). At the end of the follow-up period, uncorrected visual acuity was 20/50 or better in three of 30 treated eyes (10%) and 20/100 or better in 25 of 30 treated eyes (83.3%). No intraoperative complications were observed, but the following postoperative complications were seen in seven of 30 (23.2%) eyes: four eyes (13.3%) developed irregular astigmatism, one eye (3.3%) had poor night vision, and two eyes (6.6%) had irregularities in Bowman's membrane. The operation was repeated with homoplastic material in one of the two eyes with Bowman's membrane irregularities after six months, because of central alterations in Bowman's membrane.

Entities:  

Mesh:

Year:  1992        PMID: 1543222     DOI: 10.1016/s0002-9394(14)71581-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

1.  Laser intrastromal keratomileusis for high myopia and myopic astigmatism.

Authors:  P I Condon; M Mulhern; T Fulcher; A Foley-Nolan; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

2.  Effect of ablation profile on wound healing and visual performance 1 year after excimer laser photorefractive keratectomy.

Authors:  M C Corbett; S Verma; D P O'Brart; K M Oliver; G Heacock; J Marshall
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

3.  The 2014 Bowman Lecture-Bowman's and Bruch's: a tale of two membranes during the laser revolution.

Authors:  J Marshall
Journal:  Eye (Lond)       Date:  2015-01       Impact factor: 3.775

4.  Journey from photorefractive keratectomy to small incision lenticule extraction.

Authors:  Rupal Shah
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

5.  Corneal wound healing following laser in situ keratomileusis (LASIK): a histopathological study in rabbits.

Authors:  T Kato; K Nakayasu; Y Hosoda; Y Watanabe; A Kanai
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

6.  Optics of conductive keratoplasty: implications for presbyopia management.

Authors:  Peter S Hersh
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 7.  Photorefractive keratectomy: implications of corneal wound healing.

Authors:  S J Tuft; D S Gartry; I M Rawe; K M Meek
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

8.  Laser In Situ keratomileusis (LASIK) for the treatment of low moderate, and high myopia.

Authors:  R L Lindstrom; D R Hardten; Y R Chu
Journal:  Trans Am Ophthalmol Soc       Date:  1997

9.  [Ablation on the undersurface of a LASIK flap. Instrument and method for continuous eye tracking].

Authors:  S Taneri; D T Azar
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

Review 10.  Femtosecond laser in laser in situ keratomileusis.

Authors:  Marcella Q Salomão; Steven E Wilson
Journal:  J Cataract Refract Surg       Date:  2010-06       Impact factor: 3.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.